Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/01/24 08:00:07 on US and Canada Markets.
2024-04-01 08:00:07 ET Gus Richard from Northland Securities issued a price target of $36.50 for SMTC on 2024-04-01 06:47:00. The adjusted price target was set to $36.50. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is a...
2024-04-01 08:00:06 ET Harsh Kumar from Piper Sandler issued a price target of $40.00 for SMTC on 2024-04-01 06:45:00. The adjusted price target was set to $40.00. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is at $36.5...
2024-04-01 08:00:06 ET Tristan Gerra from Robert W. Baird issued a price target of $50.00 for SMTC on 2024-04-01 06:46:00. The adjusted price target was set to $50.00. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is at $...
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 5,454,548 shares of the Company’s common sto...
Scienjoy Subsidiary, Scienjoy Meta Technology L.L.C, Introduces AI Mate & AI Vision: Entering a New Era of Predictive Personal Assistance Scienjoy Subsidiary, Scienjoy Meta Technology L.L.C, Introduces AI Mate & AI Vision: Entering a New Era of Predictive Personal Assistance ...
WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...
Topline data delivered to Ono Pharmaceutical, representing the first of two data sets that will trigger Ono’s option exercise decision for itolizumab Itolizumab continues to show clinically meaningful response in highly proteinuric subjects More than 80% of subjects achieve...
WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...
First of its kind study in muscle-invasive urothelial cancer, with both escalation and de-escalation arms Approximately 1,000 patients will be enrolled at more than 300 sites Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and the Alliance for Clinical...
Politan’s Efforts to Take Control of Masimo Are Not in Stockholders’ Best Interests Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election to ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.97%Change Percent:
Rimini Street Inc. Company Name:
RMNI Stock Symbol:
NASDAQ Market:
riministreet.com Website: